Organogenesis Holdings Inc.
ORGO
$4.88
$0.214.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.97% | -11.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.97% | -11.56% | |||
| Cost of Revenue | 15.88% | -8.23% | |||
| Gross Profit | 8.17% | -12.53% | |||
| SG&A Expenses | 2.87% | -6.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.89% | -10.21% | |||
| Operating Income | 63.71% | -29.94% | |||
| Income Before Tax | 76.08% | 140.05% | |||
| Income Tax Expenses | 139.64% | -360.01% | |||
| Earnings from Continuing Operations | -37.77% | 172.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.77% | 172.35% | |||
| EBIT | 63.71% | -29.94% | |||
| EBITDA | 37.78% | -18.79% | |||
| EPS Basic | -51.29% | 172.32% | |||
| Normalized Basic EPS | 79.64% | -29.31% | |||
| EPS Diluted | -55.44% | 169.23% | |||
| Normalized Diluted EPS | 78.31% | -30.08% | |||
| Average Basic Shares Outstanding | -2.18% | 0.00% | |||
| Average Diluted Shares Outstanding | -1.32% | 1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||